Sanofi (SNY) Common Equity (2009 - 2026)
Sanofi (SNY) recorded Common Equity of $80.86 billion in the quarter ended Jun 30, 2026, up 1.6% from $79.55 billion a year earlier.
Powered by 
Analysis
Sanofi (SNY) Common Equity (2009 - 2026) Analysis & Trends
As of Dec 31, 2025, Sanofi reported Common Equity of $81.02 billion, down 3.9% from the prior year.
- Annual Common Equity has a five-year compound annual growth rate of 2.3% (years ended Dec 2020 to Dec 2025).
- Across earlier years, Common Equity came in at $84.27 billion in the year ended Dec 31, 2024 (+4.8%), $80.43 billion in the year ended Dec 31, 2023 (+1.5%), $79.21 billion in the year ended Dec 31, 2022 (-3.0%) and $81.69 billion in the year ended Dec 31, 2021 (+13.1%).
- Quarterly Common Equity has ranged from $76.09 billion in the quarter ended Jun 30, 2022 to $83.47 billion in the quarter ended Dec 31, 2025 over the past five years.
- Peak year-over-year performance for Common Equity in the last five years was growth of 4.7% in the quarter ended Dec 31, 2021, against a decline of 2.9% in the quarter ended Dec 31, 2022 at the low end.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,144.36 Bn | 1,112.95 Bn | 19.71 Bn | 33.88 Bn |
| 2 | Johnson & Johnson | 635.36 Bn | 555.22 Bn | 17.30 Bn | 81.53 Bn |
| 3 | AbbVie | 502.79 Bn | 475.90 Bn | 12.70 Bn | -5.94 Bn |
| 4 | Merck | 356.08 Bn | 310.46 Bn | 12.21 Bn | 41.98 Bn |
| 5 | Novartis Ag | 300.87 Bn | 264.86 Bn | 11.24 Bn | 41.95 Bn |
| 6 | Astrazeneca | 264.31 Bn | 237.99 Bn | 12.86 Bn | 50.37 Bn |
| 7 | Amgen | 239.07 Bn | 194.47 Bn | 7.24 Bn | 11.69 Bn |
| 8 | Gilead Sciences | 194.50 Bn | 168.70 Bn | 6.22 Bn | 11.83 Bn |
| 9 | Pfizer | 171.00 Bn | 117.64 Bn | 10.94 Bn | 85.49 Bn |
| 10 | Sanofi | 50.63 Bn | 17.15 Bn | 10.79 Bn | 79.05 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 79.05 Bn |
| Dec 31, 2025 | 83.85 Bn |
| Jun 30, 2025 | 82.42 Bn |
| Dec 31, 2024 | 81.02 Bn |
| Jun 30, 2024 | 77.84 Bn |
| Dec 31, 2023 | 81.95 Bn |
| Jun 30, 2023 | 78.93 Bn |
| Dec 31, 2022 | 79.73 Bn |
| Jun 30, 2022 | 74.12 Bn |
| Dec 31, 2021 | 77.78 Bn |
| Jun 30, 2021 | 75.26 Bn |
| Dec 31, 2020 | 77.62 Bn |
| Jun 30, 2020 | 71.20 Bn |
| Dec 31, 2019 | 66.35 Bn |
| Jun 30, 2019 | 64.28 Bn |
| Dec 31, 2018 | 67.54 Bn |
| Mar 31, 2018 | 71.67 Bn |
| Dec 31, 2017 | 69.55 Bn |
| Jun 30, 2017 | 66.12 Bn |
| Dec 31, 2016 | 61.04 Bn |
API Access
Sanofi Common Equity API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=common-equity&ticker=SNY&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "common-equity", "ticker": "SNY", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=common-equity&ticker=SNY&period=max&api_key=YOUR_API_KEY");
const data = await res.json();